BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19273323)

  • 1. Deregulation of calcium fluxes in HTLV-I infected CD4-positive T-cells plays a major role in malignant transformation.
    Akl H; Badran B; El Zein N; Dobirta G; Burny A; Martiat P
    Front Biosci (Landmark Ed); 2009 Jan; 14(10):3925-34. PubMed ID: 19273323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation.
    Akl H; Badran BM; Zein NE; Bex F; Sotiriou C; Willard-Gallo KE; Burny A; Martiat P
    Leukemia; 2007 Apr; 21(4):788-96. PubMed ID: 17287851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential Role of Human T Cell Leukemia Virus Type 1
    Galli V; Nixon CC; Strbo N; Artesi M; de Castro-Amarante MF; McKinnon K; Fujikawa D; Omsland M; Washington-Parks R; Romero L; Caruso B; Durkin K; Brown S; Karim B; Vaccari M; Jacobson S; Zack JA; Van den Broeke A; Pise-Masison C; Franchini G
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J; Zhang D; Zhou C; Marasco WA
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
    Macaire H; Riquet A; Moncollin V; Biémont-Trescol MC; Duc Dodon M; Hermine O; Debaud AL; Mahieux R; Mesnard JM; Pierre M; Gazzolo L; Bonnefoy N; Valentin H
    J Biol Chem; 2012 Jun; 287(25):21357-70. PubMed ID: 22553204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).
    Albrecht B; D'Souza CD; Ding W; Tridandapani S; Coggeshall KM; Lairmore MD
    J Virol; 2002 Apr; 76(7):3493-501. PubMed ID: 11884573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.
    Thénoz M; Vernin C; Mortada H; Karam M; Pinatel C; Gessain A; Webb TR; Auboeuf D; Wattel E; Mortreux F
    Retrovirology; 2014 Dec; 11():119. PubMed ID: 25519886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
    Ruggero K; Guffanti A; Corradin A; Sharma VK; De Bellis G; Corti G; Grassi A; Zanovello P; Bronte V; Ciminale V; D'Agostino DM
    J Virol; 2014 Apr; 88(7):3612-22. PubMed ID: 24403582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype.
    Zane L; Sibon D; Mortreux F; Wattel E
    Front Biosci (Landmark Ed); 2009 Jan; 14(10):3935-41. PubMed ID: 19273324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.
    Bindhu M; Nair A; Lairmore MD
    Front Biosci; 2004 Sep; 9():2556-76. PubMed ID: 15358581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-cell leukemia/lymphoma (ATLL): report of two fully documented Hellenic patients.
    Kokoris SI; Siakantaris MP; Kontopidou FN; Kyrtsonis MC; Tsakris A; Spanakis N; Anargyrou K; Vassilakopoulos TP; Viniou NA; Korkolopoulou P; Dimitrakopoulou AD; Legakis N; Pangalis GA
    Leuk Lymphoma; 2004 Apr; 45(4):715-21. PubMed ID: 15160945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features.
    Ohshima K; Suzumiya J; Kato A; Tashiro K; Kikuchi M
    Int J Cancer; 1997 Aug; 72(4):592-8. PubMed ID: 9259396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
    Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
    Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1-infected thymic epithelial cells convey the virus to CD4
    Carvalho Barros LR; Linhares-Lacerda L; Moreira-Ramos K; Ribeiro-Alves M; Machado Motta MC; Bou-Habib DC; Savino W
    Immunobiology; 2017 Dec; 222(12):1053-1063. PubMed ID: 28888743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
    Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
    Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30
    Hutchison T; Malu A; Yapindi L; Bergeson R; Peck K; Romeo M; Harrod C; Pope J; Smitherman L; Gwinn W; Ratner L; Yates C; Harrod R
    Virology; 2018 Jul; 520():39-58. PubMed ID: 29777913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
    Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
    Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.
    Jain P; Lavorgna A; Sehgal M; Gao L; Ginwala R; Sagar D; Harhaj EW; Khan ZK
    Retrovirology; 2015 Feb; 12():23. PubMed ID: 25809782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.